Helping youth in the juvenile justice system reduce substance use through mentoring
Mentoring to reduce substance use for youth in the juvenile justice system
This study is all about helping young people in the juvenile justice system who are dealing with substance use and mental health challenges by creating easy-to-use digital tools that can support them, while also training new researchers to improve care in this important area.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10669168 on NIH RePORTER |
What this research studies
This research focuses on supporting youth involved in the juvenile justice system by addressing substance use and mental health issues. It aims to develop and test digital health interventions that can effectively engage these vulnerable populations. The project also emphasizes mentoring junior researchers to advance the science of behavioral health in this area. By leveraging mobile health technologies, the research seeks to provide accessible and effective care for these youth.
Who could benefit from this research
Good fit: Ideal candidates for this research are youth aged 0-21 who are involved in the juvenile justice system and are struggling with substance use or mental health issues.
Not a fit: Patients who are not involved in the juvenile justice system or do not have substance use or mental health concerns may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved mental health and reduced substance use among youth in the juvenile justice system.
How similar studies have performed: Previous research has shown that digital health interventions can be effective in improving outcomes for underserved populations, indicating a promising approach in this area.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Tolou-Shams, Marina — University of California, San Francisco
- Study coordinator: Tolou-Shams, Marina
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.